Answer
Breyanzi (lisocabtagene maraleucel) is administered intravenously only.
Sources for this answer
- Breyanzi 1.1-70 × 10^6 cells/mL / 1.1-70 × 10^6 cells/mL dispersion for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked